The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
The hallucinogenic world of tryptamines: an updated review
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
González-Maeso, J., Weisstaub, N. V., Zhou, M., Chan, P., Ivic, L., Ang, R., Lira, A., Bradley-Moore, M., Ge, Y., Zhou, Q., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.008 · Cited by 925
The Toxicology of Bath Salts: A Review of Synthetic Cathinones
Prosser, J. M., & Nelson, L. S. (2012) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0193-z · Cited by 705
Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., Darland, T., Suchland, K. L., Pasumamula, S., Kennedy, J. L., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1181 · Cited by 648
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents
Glennon, R. A., Titeler, M., & McKenney, J. D. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90436-3 · Cited by 631
The Hallucinogen N,N -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator
Fontanilla, D., Johannessen, M., Hajipour, A. R., Cozzi, N. V., Jackson, M. B., & Ruoho, A. E. (2009) · Science · doi:10.1126/science.1166127 · Cited by 535 · cited 1×
“DMT is described as sigma-1 (σ1) receptor agonist with moderate affinity (Fontanilla et al. 2009), although this is not its main interaction , since DMT affinity for 5-HT 1A and 5-HT 2A receptors is twice greater than for σ1 (Halberstadt and Geyer 2011).”
BackgroundSerotonin Content of Some Mammalian Tissues and Urine and a Method for Its Determination
Twarog, B. M., & Page, I. H. (1953) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1953.175.1.157 · Cited by 532
Seely, K. A., Lapoint, J., Moran, J. H., & Fattore, L. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.04.017 · Cited by 465
Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453
Hasler, F., Grimberg, U., Benz, M. A., Huber, T., & Vollenweider, F. X. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1640-6 · Cited by 451 · cited 2×
“The onset of effects for psilocybin is around 20–40 min, lasting 4–6 h after oral administration (Hasler et al. 2004).”
Background
Cited by
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
Rickli, A., Moning, O. D., Hoener, M. C., & Liechti, M. E. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.05.001 · Cited by 379
Davis, A. K., Barrett, F. S., & Griffiths, R. R. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.004 · Cited by 375
Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods
Lisdahl, K. M., Sher, K. J., Conway, K. P., Gonzalez, R., Feldstein Ewing, S. W., Nixon, S. J., Tapert, S., Bartsch, H., Goldstein, R. Z., & Heitzeg, M. (2018) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2018.02.007 · Cited by 361
Designer drugs: mechanism of action and adverse effects
Luethi, D., & Liechti, M. E. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02693-7 · Cited by 262
Barker, S. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00536 · Cited by 177
Metadata
- Authors
- Araújo, A. M., Carvalho, F., Bastos, M. D. L., Guedes de Pinho, P., & Carvalho, M.
- Venue
- Archives of Toxicology
- Published
- 2015-04-16
- Volume
- 89
- Issue
- 8
- Pages
- 1151-1173
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W2018957682
- Cited by
- 292
- References
- 167
- FWCI
- 21.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The hallucinogenic world of tryptamines: an updated review. https://app.cochat.ai/papers/10.1007/s00204-015-1513-x
- The paper
- Araújo, A. M., Carvalho, F., Bastos, M. D. L., Guedes de Pinho, P., & Carvalho, M. (2015). The hallucinogenic world of tryptamines: an updated review. Archives of Toxicology. https://doi.org/10.1007/s00204-015-1513-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.